Clinical Trial Update: Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver [Phase 1]

View source ↗

Summary

A Phase I trial evaluating disulfiram in combination with copper gluconate for refractory solid tumors involving the liver has completed, with dose-escalation s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Copper gluconate (copper gluconate)
• Disulfiram (Disulfiram)

Snippet

Sponsor: University of Utah | Conditions: Cancer | Phase 1 | Status: COMPLETED